These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1463779)

  • 1. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
    Vaidyanathan G; Zalutsky MR
    Bioconjug Chem; 1992; 3(6):499-503. PubMed ID: 1463779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
    Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1996; 7(1):102-7. PubMed ID: 8741997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
    Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
    Nucl Med Biol; 1996 Aug; 23(6):851-6. PubMed ID: 8940730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
    Vaidyanathan G; Strickland DK; Zalutsky MR
    Int J Cancer; 1994 Jun; 57(6):908-13. PubMed ID: 8206683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
    Batra V; Samanta M; Makvandi M; Groff D; Martorano P; Elias J; Ranieri P; Tsang M; Hou C; Li Y; Pawel B; Martinez D; Vaidyanathan G; Carlin S; Pryma DA; Maris JM
    Clin Cancer Res; 2022 Sep; 28(18):4146-4157. PubMed ID: 35861867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
    Strickland DK; Vaidyanathan G; Friedman HS; Zalutsky MR
    J Neurooncol; 1995; 25(1):9-17. PubMed ID: 8523094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
    Strickland DK; Vaidyanathan G; Zalutsky MR
    Cancer Res; 1994 Oct; 54(20):5414-9. PubMed ID: 7923174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
    Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
    Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1995 Jan; 22(1):61-4. PubMed ID: 7735171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
    Cunningham SH; Mairs RJ; Wheldon TE; Welsh PC; Vaidyanathan G; Zalutsky MR
    Br J Cancer; 1998 Jun; 77(12):2061-8. PubMed ID: 9649115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments.
    Vaidyanathan G; Affleck D; Zalutsky MR
    Nucl Med Biol; 1994 Jan; 21(1):105-10. PubMed ID: 9234271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
    Fullerton NE; Boyd M; Ross SC; Pimlott SL; Babich J; Kirk D; Zalutsky MR; Mairs RJ
    Med Chem; 2005 Nov; 1(6):611-8. PubMed ID: 16787344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kit method for the high level synthesis of [211At]MABG.
    Vaidyanathan G; Affleck DJ; Alston KL; Zhao XG; Hens M; Hunter DH; Babich J; Zalutsky MR
    Bioorg Med Chem; 2007 May; 15(10):3430-6. PubMed ID: 17387017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.
    Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide.
    Garg PK; John CS; Zalutsky MR
    Nucl Med Biol; 1995 May; 22(4):467-73. PubMed ID: 7550023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.